A Study to Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1

Completed

Conditions studied: HIV Infections

In brief

The purpose of this study is to evaluate the long-term consequences of HIV-1 infections that occurred in association with known, but discouraged, high-risk behaviors in persons who have received HIV candidate vaccines or placebo in HIVNET 014. Doctors need to look at how these patients respond to HIV infection in order to develop new HIV vaccines and other treatments for HIV and AIDS. Patients who receive HIV vaccines are sometimes protected from HIV infection. More often, these patients become HIV-positive but experience a boost in their immune system that helps their bodies fight HIV. Doctors need to look at how these patients respond to HIV infection in order to develop new HIV vaccines and other treatments for HIV and AIDS.

Key facts

Study ID

NCT00001121

Run by

National Institute of Allergy and Infectious Diseases (NIAID)

Starts

1999-08-01

Last updated by the study team

2008-09-12

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients may be eligible for this study if they:
• Become infected with HIV while participating in HIVNET 014, or if they are an HIV-positive partner (sexual or needle-sharing) of a HIVNET 014A participant.
• Are able and willing to provide written informed consent.

You may not qualify if…

• Patients will not be eligible for this study if they:
• Have a serious psychiatric or psychological disorder that would prevent them from completing the study.

Where it is running

• San Francisco Dept of Hlth / AIDS Office — San Francisco, California, United States
• Denver Dept of Public Health / HIVNET — Denver, Colorado, United States
• Univ of Illinois Chicago / Howard Brown Hlth Ctr — Chicago, Illinois, United States
• Howard Brown Health Ctr / HIVNET — Chicago, Illinois, United States
• Fenway Community Health Ctr / HIVNET — Boston, Massachusetts, United States
• New York Univ Med Ctr — New York, New York, United States
• New York Blood Ctr — The Bronx, New York, United States
• Univ of Pennsylvania / HIVNET — Philadelphia, Pennsylvania, United States
• Mem Hosp of Rhode Island — Pawtucket, Rhode Island, United States
• Miriam Hosp — Providence, Rhode Island, United States
• Univ of Washington — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.